SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-002770
Filing Date
2024-04-05
Accepted
2024-04-05 16:05:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 p24-1385sc13g.htm SC 13G 73768
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-1385exhibit99.htm EX-99.1 8938
  Complete submission text file 0000902664-24-002770.txt   84331
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90656 | Film No.: 24826488
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G